This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morath, S.
Right arrow Articles by Hartung, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morath, S.
Right arrow Articles by Hartung, T.

 Previous Article  |  Next Article 

Infection and Immunity, February 2002, p. 938-944, Vol. 70, No. 2
0019-9567/01/$04.00+0     DOI: 70.2.938-944.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Structural Decomposition and Heterogeneity of Commercial Lipoteichoic Acid Preparations

Siegfried Morath, Armin Geyer, Ingo Spreitzer, Corinna Hermann, and Thomas Hartung*

University of Konstanz, Biochemical Pharmacology, Konstanz, Germany

Received 3 August 2001/ Returned for modification 7 September 2001/ Accepted 1 November 2001

Fractionation of commercial preparations of lipoteichoic acids (LTA) by hydrophobic interaction chromatography (HIC) and nuclear magnetic resonance spectroscopy revealed very inhomogeneous compositions and decomposition of the LTA structure: LTA content of the preparations averaged 61% for Streptococcus pyogenes, 16% for Bacillus subtilis, and 75% for Staphylococcus aureus. The decomposition was characterized by a loss of glycerophosphate units as well as alanine and N-acetylglucosamine substituents. All preparations contained—to varying degrees—non-LTA, non-lipopolysaccharide (LPS) immunostimulatory components as indicated by their elution profile in HIC, lack of phosphate, and negative Limulus amoebocyte lysate (LAL) test results. After purification, the commercial LTA from Bacillus subtilis and S. pyogenes but not LTA from S. aureus induced the release of tumor necrosis factor alpha, interleukin 1 beta (IL-1ß), IL-6, and IL-10 in human blood. While pure LTA are negative in the LAL assay, endotoxin equivalents of more than 10 ng of LPS/mg of LTA were found in the commercial preparations. Taken together, these data indicate that these crude preparations with relatively high endotoxin contamination are not suitable for characterizing the activation of immune cells by LTA.

* Corresponding author. Mailing address: University of Konstanz, Biochemical Pharmacology, 78457 Konstanz, Germany. Phone: 49-7531-884116. Fax: 49-7531-884117. E-mail: thomas.hartung{at}0040uni-konstanz.de.

Editor: J. T. Barbieri

Infection and Immunity, February 2002, p. 938-944, Vol. 70, No. 2
0019-9567/01/$04.00+0     DOI: 70.2.938-944.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Yang, J., Ryu, Y. H., Yun, C.-H., Han, S. H. (2009). Impaired osteoclastogenesis by staphylococcal lipoteichoic acid through Toll-like receptor 2 with partial involvement of MyD88. J. Leukoc. Biol. 86: 823-831 [Abstract] [Full Text]  
  • Seo, H. S., Nahm, M. H. (2009). Lipoprotein Lipase and Hydrofluoric Acid Deactivate Both Bacterial Lipoproteins and Lipoteichoic Acids, but Platelet-Activating Factor-Acetylhydrolase Degrades Only Lipoteichoic Acids. CVI 16: 1187-1195 [Abstract] [Full Text]  
  • Seo, H. S., Michalek, S. M., Nahm, M. H. (2008). Lipoteichoic Acid Is Important in Innate Immune Responses to Gram-Positive Bacteria. Infect. Immun. 76: 206-213 [Abstract] [Full Text]  
  • Deininger, S., Figueroa-Perez, I., Sigel, S., Stadelmaier, A., Schmidt, R. R., Hartung, T., von Aulock, S. (2007). Use of Synthetic Derivatives To Determine the Minimal Active Structure of Cytokine-Inducing Lipoteichoic Acid. CVI 14: 1629-1633 [Abstract] [Full Text]  
  • Hermann, C. (2007). Review: Variability of host pathogen interaction. Innate Immunity 13: 199-218 [Abstract]  
  • von Aulock, S., Hartung, T., Hermann, C. (2007). Comment on "Not Lipoteichoic Acid but Lipoproteins Appear to Be the Dominant Immunobiologically Active Compounds in Staphylococcus aureus". J. Immunol. 178: 2610-2610 [Full Text]  
  • Mullaly, S. C., Kubes, P. (2006). The Role of TLR2 In Vivo following Challenge with Staphylococcus aureus and Prototypic Ligands. J. Immunol. 177: 8154-8163 [Abstract] [Full Text]  
  • Draing, C., Pfitzenmaier, M., Zummo, S., Mancuso, G., Geyer, A., Hartung, T., von Aulock, S. (2006). Comparison of Lipoteichoic Acid from Different Serotypes of Streptococcus pneumoniae. J. Biol. Chem. 281: 33849-33859 [Abstract] [Full Text]  
  • Triantafilou, M., Gamper, F. G. J., Haston, R. M., Mouratis, M. A., Morath, S., Hartung, T., Triantafilou, K. (2006). Membrane Sorting of Toll-like Receptor (TLR)-2/6 and TLR2/1 Heterodimers at the Cell Surface Determines Heterotypic Associations with CD36 and Intracellular Targeting. J. Biol. Chem. 281: 31002-31011 [Abstract] [Full Text]  
  • Ohta, S., Bahrun, U., Shimazu, R., Matsushita, H., Fukudome, K., Kimoto, M. (2006). Induction of Long-Term Lipopolysaccharide Tolerance by an Agonistic Monoclonal Antibody to the Toll-Like Receptor 4/MD-2 Complex. CVI 13: 1131-1136 [Abstract] [Full Text]  
  • Kovacs, M., Halfmann, A., Fedtke, I., Heintz, M., Peschel, A., Vollmer, W., Hakenbeck, R., Bruckner, R. (2006). A Functional dlt Operon, Encoding Proteins Required for Incorporation of D-Alanine in Teichoic Acids in Gram-Positive Bacteria, Confers Resistance to Cationic Antimicrobial Peptides in Streptococcus pneumoniae. J. Bacteriol. 188: 5797-5805 [Abstract] [Full Text]  
  • Henneke, P., Berner, R. (2006). Interaction of Neonatal Phagocytes with Group B Streptococcus: Recognition and Response. Infect. Immun. 74: 3085-3095 [Full Text]  
  • Hasty, D. L., Meron-Sudai, S., Cox, K. H., Nagorna, T., Ruiz-Bustos, E., Losi, E., Courtney, H. S., Mahrous, E. A., Lee, R., Ofek, I. (2006). Monocyte and Macrophage Activation by Lipoteichoic Acid Is Independent of Alanine and Is Potentiated by Hemoglobin. J. Immunol. 176: 5567-5576 [Abstract] [Full Text]  
  • Traub, S., von Aulock, S., Hartung, T., Hermann, C. (2006). Invited review: MDP and other muropeptides direct and synergistic effects on the immune system. Innate Immunity 12: 69-85 [Abstract]  
  • Morath, S., von Aulock, S., Hartung, T. (2005). Structure/function relationships of lipoteichoic acids. Innate Immunity 11: 348-356 [Abstract]  
  • Brun, P., Castagliuolo, I., Pinzani, M., Palu, G., Martines, D. (2005). Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G571-G578 [Abstract] [Full Text]  
  • Grandel, U., Hopf, M., Buerke, M., Hattar, K., Heep, M., Fink, L., Bohle, R. M., Morath, S., Hartung, T., Pullamsetti, S., Schermuly, R. T., Seeger, W., Grimminger, F., Sibelius, U. (2005). Mechanisms of Cardiac Depression Caused by Lipoteichoic Acids From Staphylococcus aureus in Isolated Rat Hearts. Circulation 112: 691-698 [Abstract] [Full Text]  
  • Grangette, C., Nutten, S., Palumbo, E., Morath, S., Hermann, C., Dewulf, J., Pot, B., Hartung, T., Hols, P., Mercenier, A. (2005). From The Cover: Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. Natl. Acad. Sci. USA 102: 10321-10326 [Abstract] [Full Text]  
  • Fournier, B., Philpott, D. J. (2005). Recognition of Staphylococcus aureus by the Innate Immune System. Clin. Microbiol. Rev. 18: 521-540 [Abstract] [Full Text]  
  • Henneke, P., Morath, S., Uematsu, S., Weichert, S., Pfitzenmaier, M., Takeuchi, O., Muller, A., Poyart, C., Akira, S., Berner, R., Teti, G., Geyer, A., Hartung, T., Trieu-Cuot, P., Kasper, D. L., Golenbock, D. T. (2005). Role of Lipoteichoic Acid in the Phagocyte Response to Group B Streptococcus. J. Immunol. 174: 6449-6455 [Abstract] [Full Text]  
  • Triantafilou, M., Manukyan, M., Mackie, A., Morath, S., Hartung, T., Heine, H., Triantafilou, K. (2004). Lipoteichoic Acid and Toll-like Receptor 2 Internalization and Targeting to the Golgi Are Lipid Raft-dependent. J. Biol. Chem. 279: 40882-40889 [Abstract] [Full Text]  
  • Triantafilou, M., Morath, S., Mackie, A., Hartung, T., Triantafilou, K. (2004). Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J. Cell Sci. 117: 4007-4014 [Abstract] [Full Text]  
  • Armstrong, L., Medford, A. R. L., Uppington, K. M., Robertson, J., Witherden, I. R., Tetley, T. D., Millar, A. B. (2004). Expression of Functional Toll-Like Receptor-2 and -4 on Alveolar Epithelial Cells. Am. J. Respir. Cell Mol. Bio. 31: 241-245 [Abstract] [Full Text]  
  • Mattsson, E., Hartung, T., Morath, S., Egesten, A. (2004). Highly Purified Lipoteichoic Acid from Staphylococcus aureus Induces Procoagulant Activity and Tissue Factor Expression in Human Monocytes but Is a Weak Inducer in Whole Blood: Comparison with Peptidoglycan. Infect. Immun. 72: 4322-4326 [Abstract] [Full Text]  
  • von Aulock, S., Schroder, N. W. J., Traub, S., Gueinzius, K., Lorenz, E., Hartung, T., Schumann, R. R., Hermann, C. (2004). Heterozygous Toll-Like Receptor 2 Polymorphism Does Not Affect Lipoteichoic Acid-Induced Chemokine and Inflammatory Responses. Infect. Immun. 72: 1828-1831 [Abstract] [Full Text]  
  • Lotz, S., Aga, E., Wilde, I., van Zandbergen, G., Hartung, T., Solbach, W., Laskay, T. (2004). Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J. Leukoc. Biol. 75: 467-477 [Abstract] [Full Text]  
  • Lynch, N. J., Roscher, S., Hartung, T., Morath, S., Matsushita, M., Maennel, D. N., Kuraya, M., Fujita, T., Schwaeble, W. J. (2004). L-Ficolin Specifically Binds to Lipoteichoic Acid, a Cell Wall Constituent of Gram-Positive Bacteria, and Activates the Lectin Pathway of Complement. J. Immunol. 172: 1198-1202 [Abstract] [Full Text]  
  • Neuhaus, F. C., Baddiley, J. (2003). A Continuum of Anionic Charge: Structures and Functions of D-Alanyl-Teichoic Acids in Gram-Positive Bacteria. Microbiol. Mol. Biol. Rev. 67: 686-723 [Abstract] [Full Text]  
  • Moller, A.-S. W., Ovstebo, R., Westvik, A.-B., Joo, G. B., Haug, K.-B. F., Kierulf, P. (2003). Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1{alpha} (MIP-1{alpha}) and the chemokine receptor CCR2 by purified human blood monocytes. Innate Immunity 9: 349-360 [Abstract]  
  • Han, S. H., Kim, J. H., Martin, M., Michalek, S. M., Nahm, M. H. (2003). Pneumococcal Lipoteichoic Acid (LTA) Is Not as Potent as Staphylococcal LTA in Stimulating Toll-Like Receptor 2. Infect. Immun. 71: 5541-5548 [Abstract] [Full Text]  
  • Levels, J. H. M., Abraham, P. R., van Barreveld, E. P., Meijers, J. C. M., van Deventer, S. J. H. (2003). Distribution and Kinetics of Lipoprotein-Bound Lipoteichoic Acid. Infect. Immun. 71: 3280-3284 [Abstract] [Full Text]  
  • Schroder, N. W. J., Morath, S., Alexander, C., Hamann, L., Hartung, T., Zahringer, U., Gobel, U. B., Weber, J. R., Schumann, R. R. (2003). Lipoteichoic Acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus Activates Immune Cells via Toll-like Receptor (TLR)-2, Lipopolysaccharide-binding Protein (LBP), and CD14, whereas TLR-4 and MD-2 Are Not Involved. J. Biol. Chem. 278: 15587-15594 [Abstract] [Full Text]  
  • Deininger, S., Stadelmaier, A., von Aulock, S., Morath, S., Schmidt, R. R., Hartung, T. (2003). Definition of Structural Prerequisites for Lipoteichoic Acid-Inducible Cytokine Induction by Synthetic Derivatives. J. Immunol. 170: 4134-4138 [Abstract] [Full Text]  
  • Takada, H., Yokoyama, S., Shuhua Yang, (2002). Mini-review: Enhancement of endotoxin activity by muramyldipeptide. Innate Immunity 8: 337-342 [Abstract]  
  • Morath, S., Stadelmaier, A., Geyer, A., Schmidt, R. R., Hartung, T. (2002). Synthetic Lipoteichoic Acid from Staphylococcus aureus Is a Potent Stimulus of Cytokine Release. JEM 195: 1635-1640 [Abstract] [Full Text]  
  • Mattsson, E., Herwald, H., Bjorck, L., Egesten, A. (2002). Peptidoglycan from Staphylococcus aureus Induces Tissue Factor Expression and Procoagulant Activity in Human Monocytes. Infect. Immun. 70: 3033-3039 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»